Abstract
Informed consent represents a major step in respect for patient autonomy. However, most cancer patients participating in a trial are based on the pressure of disease progression and trust of physicians. Therefore, it is necessary to explore influential factors of patient autonomous decision when considering cancer trials.
Sigma Membership
Lambda Beta at-Large
Lead Author Affiliation
National Cheng Kung University, Tainan, Taiwan
Type
Poster
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Autonomy, Cancer, Clinical Trial
Recommended Citation
Kao, Chi-Yin; Huang, Mei-Chih; Hu, Wen-Yu; Yang, Chih-Hsin; and Su, Wu-Chou, "Factors to influence autonomous decision making by patients in cancer clinical trials" (2018). INRC (Congress). 84.
https://www.sigmarepository.org/inrc/2018/posters_2018/84
Conference Name
29th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Melbourne, Australia
Conference Year
2018
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Factors to influence autonomous decision making by patients in cancer clinical trials
Melbourne, Australia
Informed consent represents a major step in respect for patient autonomy. However, most cancer patients participating in a trial are based on the pressure of disease progression and trust of physicians. Therefore, it is necessary to explore influential factors of patient autonomous decision when considering cancer trials.